NO20061354L - Fremgangsmater og sammensetninger for oral administrering av prodroger av protonpumpe inhibitatorer - Google Patents
Fremgangsmater og sammensetninger for oral administrering av prodroger av protonpumpe inhibitatorerInfo
- Publication number
- NO20061354L NO20061354L NO20061354A NO20061354A NO20061354L NO 20061354 L NO20061354 L NO 20061354L NO 20061354 A NO20061354 A NO 20061354A NO 20061354 A NO20061354 A NO 20061354A NO 20061354 L NO20061354 L NO 20061354L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- proton pump
- pump inhibitor
- compositions
- oral administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50835603P | 2003-10-03 | 2003-10-03 | |
US51388003P | 2003-10-22 | 2003-10-22 | |
PCT/US2004/032099 WO2005034951A1 (en) | 2003-10-03 | 2004-10-01 | Methods and compositions for the oral administration of prodrugs of proton pump inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20061354L true NO20061354L (no) | 2006-05-03 |
Family
ID=34437281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20061354A NO20061354L (no) | 2003-10-03 | 2006-03-24 | Fremgangsmater og sammensetninger for oral administrering av prodroger av protonpumpe inhibitatorer |
Country Status (13)
Country | Link |
---|---|
US (1) | US20050075371A1 (zh) |
EP (1) | EP1670467A1 (zh) |
JP (1) | JP2007518700A (zh) |
KR (1) | KR20060082082A (zh) |
AR (1) | AR045857A1 (zh) |
AU (1) | AU2004279378A1 (zh) |
BR (1) | BRPI0415044A (zh) |
CA (1) | CA2540977A1 (zh) |
IL (1) | IL174265A0 (zh) |
MX (1) | MXPA06003461A (zh) |
NO (1) | NO20061354L (zh) |
TW (1) | TW200522956A (zh) |
WO (1) | WO2005034951A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005216862A1 (en) * | 2004-02-18 | 2005-09-09 | Allergan, Inc. | Compositions comprising prodrugs of proton pump inhibitors |
US20070161679A1 (en) * | 2004-02-18 | 2007-07-12 | Allergan, Inc. | Method and compositions for the intravenous administration of compounds related to proton pump inhibitors |
US20070265311A1 (en) * | 2006-01-10 | 2007-11-15 | Rubino Mark P | Therapeutic Salt Compositions and Methods |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE416649B (sv) * | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
IL76839A (en) * | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
SE8505112D0 (sv) * | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
FI90544C (fi) * | 1986-11-13 | 1994-02-25 | Eisai Co Ltd | Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi |
US4965269A (en) * | 1989-12-20 | 1990-10-23 | Ab Hassle | Therapeutically active chloro substituted benzimidazoles |
HUT62882A (en) * | 1990-06-20 | 1993-06-28 | Astra Ab | Process for producing dialkoxy pyridylmethyl sulfinyl benzimidazole derivatives and pharmaceutical compositions comprising same |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
US5708017A (en) * | 1995-04-04 | 1998-01-13 | Merck & Co., Inc. | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
SE510650C2 (sv) * | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
US6093734A (en) * | 1998-08-10 | 2000-07-25 | Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin | Prodrugs of proton pump inhibitors |
YU10101A (sh) * | 1998-08-10 | 2003-10-31 | Partnership Of Michael E. Garst George Sachs And Jai Moo Shin | Prolekovi inhibitori proton pumpe |
MXPA05000657A (es) * | 2002-07-19 | 2005-08-19 | Winston Pharmaceuticals Llc | Profarmacos de los inhibidores de bomba de protones. |
WO2005016917A1 (en) * | 2003-07-15 | 2005-02-24 | Allergan, Inc. | Process for preparing isomerically pure prodrugs of proton pump inhibitors |
-
2004
- 2004-09-17 US US10/943,411 patent/US20050075371A1/en not_active Abandoned
- 2004-09-29 TW TW093129421A patent/TW200522956A/zh unknown
- 2004-10-01 EP EP04785301A patent/EP1670467A1/en not_active Withdrawn
- 2004-10-01 KR KR1020067006439A patent/KR20060082082A/ko not_active Application Discontinuation
- 2004-10-01 JP JP2006534083A patent/JP2007518700A/ja active Pending
- 2004-10-01 AR ARP040103586A patent/AR045857A1/es not_active Application Discontinuation
- 2004-10-01 MX MXPA06003461A patent/MXPA06003461A/es not_active Application Discontinuation
- 2004-10-01 BR BRPI0415044-9A patent/BRPI0415044A/pt not_active IP Right Cessation
- 2004-10-01 WO PCT/US2004/032099 patent/WO2005034951A1/en active Application Filing
- 2004-10-01 CA CA002540977A patent/CA2540977A1/en not_active Abandoned
- 2004-10-01 AU AU2004279378A patent/AU2004279378A1/en not_active Abandoned
-
2006
- 2006-03-12 IL IL174265A patent/IL174265A0/en unknown
- 2006-03-24 NO NO20061354A patent/NO20061354L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20060082082A (ko) | 2006-07-14 |
IL174265A0 (en) | 2006-08-01 |
AU2004279378A1 (en) | 2005-04-21 |
US20050075371A1 (en) | 2005-04-07 |
JP2007518700A (ja) | 2007-07-12 |
CA2540977A1 (en) | 2005-04-21 |
EP1670467A1 (en) | 2006-06-21 |
BRPI0415044A (pt) | 2006-12-12 |
WO2005034951A1 (en) | 2005-04-21 |
MXPA06003461A (es) | 2006-06-05 |
AR045857A1 (es) | 2005-11-16 |
TW200522956A (en) | 2005-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2338311A1 (en) | Prodrugs of the pyridyl methyl sulfinyl benzimidazoles | |
NO20062905L (no) | Nye hydroksaminsyreestere og farmasoytisk anvendelse derav | |
IS8230A (is) | Setið 2-amínótetralín til notkunar við meðferð á þunglyndi | |
NO20060114L (no) | Naftylenderivater som cytokrom P450-inhibitorer | |
NO20061432L (no) | N3 alkylerte benzimidazolederivater som MEK-inhibitorer | |
CY1112831T1 (el) | Παραγωγα αζαβιρηενυlαμινοβενζοιc acid σαν παραγοντες καταστολης dhodh | |
NO20092033L (no) | Nye forbindelser | |
NO20073831L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
BRPI0418245B8 (pt) | composto derivado de nitróxi de prostaglandina, processo para preparar dito composto, composição farmacêutica compreendendo dito composto e usos destes | |
NO20054260L (no) | Disepergebar formulering av en anti-inflammatorisk forbindelse | |
ATE341550T1 (de) | Quinolinyl-pyrrolopyrazole | |
SG2013013339A (en) | N3 alkylated benzimidazole derivatives as mek inhibitors | |
NO20050801L (no) | Prodrug av protonpumpe inhibitorer | |
NO20050667L (no) | N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes | |
NO20083836L (no) | N-hydroksyakrylamidforbindelser | |
NO20081942L (no) | Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser | |
PE20050822A1 (es) | Derivados de florfenicol con mejor solubilidad en agua | |
NO20040074L (no) | Fremgangsmåte for fremstilling av benzimidazoltype forbindelser | |
NO20073830L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
SE0202429D0 (sv) | Novel Compounds | |
AU2002215932A1 (en) | Nitroderivatives as drugs for diseases having an inflammatory basis | |
NO20061354L (no) | Fremgangsmater og sammensetninger for oral administrering av prodroger av protonpumpe inhibitatorer | |
NO20063859L (no) | Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter | |
EP2103610A4 (en) | SALTS OF IMIDAZOLE-5-CARBOXYLIC ACID DERIVATIVES, METHOD OF MANUFACTURE AND USE THEREOF | |
NO20054418L (no) | Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |